Results 21 to 30 of about 784,373 (290)

Optimizing the Start Time of Biologics in Polyarticular Juvenile Idiopathic Arthritis: A Comparative Effectiveness Study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans

Arthritis & Rheumatology, 2021
The optimal time to start biologics in polyarticular juvenile idiopathic arthritis (JIA) remains uncertain. The Childhood Arthritis and Rheumatology Research Alliance (CARRA) developed 3 consensus treatment plans (CTPs) for untreated polyarticular JIA to
Y. Kimura, L. Schanberg, G. Tomlinson, M. Riordan, Anne C Dennos, Vincent Del Gaizo, Katherine L Murphy, P. Weiss, Marc D Natter M, Brian M. Feldman, S. Ringold, H. Stapp   +11 more
semanticscholar   +1 more source

Profiling risk factors for chronic uveitis in juvenile idiopathic arthritis: a new model for EHR-based research. [PDF]

, 2013
BackgroundJuvenile idiopathic arthritis is the most common rheumatic disease in children. Chronic uveitis is a common and serious comorbid condition of juvenile idiopathic arthritis, with insidious presentation and potential to cause blindness. Knowledge
Bauer-Mehren, Anna, Cole, Tyler S, Frankovich, Jennifer, Iyer, Srinivasan, Lependu, Paea, Shah, Nigam H   +5 more
core   +3 more sources

Clinical features of children with enthesitis-related juvenile idiopathic arthritis / juvenile spondyloarthritis followed in a French tertiary care pediatric rheumatology centre

Pediatric Rheumatology Online Journal, 2018
BackgroundChildhood-onset spondyloarthropathies usually start with enthesitis and peripheral arthritis. However, axial disease may develop afterward.
M. Goirand, S. Breton, Frédéric Chevallier, N. Duong, F. Uettwiller, I. Melki, R. Mouy, C. Wouters, B. Bader-Meunier, C. Job-Deslandre, P. Quartier   +10 more
semanticscholar   +1 more source

Systemic-onset juvenile idiopathic arthritis

Definitions, 2020
NATURE REVIEWS | DRUG DISCOVERY www.nature.com/reviews/drugdisc Supplementary table S1 | Broad Spectrum of Diseases Responsive to Anakinra Disease Condition References Joint, Bone and Muscle Diseases rheumatoid arthritis 1-21 psoriatic arthritis 22,23 ...

semanticscholar   +1 more source

Protocol for the Foot in Juvenile Idiopathic Arthritis trial (FiJIA): a randomised controlled trial of an integrated foot care programme for foot problems in JIA [PDF]

, 2009
<b>Background</b>: Foot and ankle problems are a common but relatively neglected manifestation of juvenile idiopathic arthritis. Studies of medical and non-medical interventions have shown that clinical outcome measures can be improved ...
A Manca, A Mavidrou, A Premkumar, B Karmazyn, CA Wallace, DD Sherry, DE Turner, Deborah E Turner, Department of Health, DG Altman, E Brostrom, E Filippucci, EGL Bywaters, EH Giannini, G Hendry, G Singh, G Spaul, GF Watt, Gordon F Watt, Gordon J Hendry, HE Foster, HE Foster, J Coast, J Ferrari, J Thornton, Janet Gardner-Medwin, JF Fries, Jim Woodburn, JJ Louviere, John McColl, KJ Murray, L Curtis, Lorraine Friel, M Andre, M Arkela-Kautiainen, M Powell, M Ryan, M Szkudlarek, MA D'Agostino, Medical Research Council Health Services and Public Health Research Board Report, Michael Browne, MJ Platto, MM Steven, N Adib, NW Scott, P Dolan, P Tynjala, Paula K Lorgelly, PJ Manners, PS Fairburn, PS Helliwell, R Brooks, R Burgos-Vargas, RE Petty, Roger D Sturrock, S Barnatsky, S Magni-Manzoni, T Beukelman, TB Graeme, W Grassi, YM El-Miedany   +60 more
core   +4 more sources

The effectiveness of a multidisciplinary foot care program for children and adolescents with juvenile idiopathic arthritis: an exploratory trial [PDF]

, 2013
Objectives: To evaluate the effectiveness of multidisciplinary foot-care, and to evaluate the methodological considerations of a trial of multidisciplinary care in juvenile idiopathic arthritis. Design: Exploratory randomised controlled trial.
Brandon, Mhairi, Friel, Lorraine, Gardner-Medwin, Janet, Hendry, Gordon, Lorgelly, Paula K., Sturrock, Roger D., Turner, Deborah, Watt, Gordon, Woodburn, James   +8 more
core   +1 more source

Evaluation of Fitness and the Balance Levels of Children with a Diagnosis of Juvenile Idiopathic Arthritis: A Pilot Study [PDF]

, 2017
Background: Juvenile idiopathic arthritis is a main cause of physical disability and has high economic costs for society. The purpose of this study was to assess the fitness levels and the postural and balance deficits with a specific test battery ...
Corsello, Giovanni, Iovane, Angelo, Maggio, Maria, Messina, Giuseppe, Palma, Antonio, Patti, Antonino   +5 more
core   +2 more sources

A national registry for juvenile dermatomyositis and other paediatric idiopathic inflammatory myopathies: 10 years' experience; the Juvenile Dermatomyositis National (UK and Ireland) Cohort Biomarker Study and Repository for Idiopathic Inflammatory Myopathies [PDF]

, 2011
Objectives: The paediatric idiopathic inflammatory myopathies (IIMs) are a group of rare chronic inflammatory disorders of childhood, affecting muscle, skin and other organs.
Bohan, Bohan, Brown, Chinoy, Chinoy, Christen-Zaech, Clarissa A. Pilkington, Constantin, Elst, Gunawardena, Gunawardena, Huber, Huber, Huber, Huber, Isenberg, Joyce E. Davidson, Kevin Murray, Kim, Li, Li, Lovell, Lowry, Lucy R. Wedderburn, Maillard, Maillard, Marhaug, McCann, McCann, McCann, Mendez, Miller, Neil Martin, Pachman, Pachman, Petra Krol, Ravelli, Rider, Rider, Rider, Rider, Riley, Riley, Sally Smith, Salomonsson, Stringer, Symmons, Varsani, Wedderburn, Wedderburn, Wedderburn   +50 more
core   +1 more source

Impact of Concomitant Methotrexate Use and Prior Biologic Disease-Modifying Antirheumatic Drug Exposure on Tofacitinib Efficacy and Safety in Patients with Polyarticular Course Juvenile Idiopathic Arthritis: Post Hoc Analysis of a Phase 3 Randomized Withdrawal Trial. [PDF]

ACR Open Rheumatol
Objective We evaluate tofacitinib efficacy and safety in patients with juvenile idiopathic arthritis (JIA) stratified by concomitant methotrexate and prior biologic disease‐modifying antirheumatic drug (bDMARD) treatment. Methods In this two part, double‐blind, randomized withdrawal Phase 3 trial (NCT02592434), patients (2–<18 years) with JIA received ...
Ruperto N, Lovell DJ, Synoverska O, Abud-Mendoza C, Spindler A, Vyzhga Y, Reyhan I, Grebenkina L, Tirosh I, Imundo L, Chiraseveenuprapund P, Kingsbury DJ, Sozeri B, Vora SS, Prahalad S, Zholobova E, Roberts KD, Sawyerr G, Blum A, Shapiro A, Diehl A, Ebrahim A, Klaus P, Martini A, Brunner HI, Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG).   +25 more
europepmc   +2 more sources

Long‐Term Outcomes in Juvenile Idiopathic Arthritis: Eighteen Years of Follow‐Up in the Population‐Based Nordic Juvenile Idiopathic Arthritis Cohort

Arthritis care & research, 2020
The present study was undertaken to assess the long‐term course, remission rate, and disease burden in juvenile idiopathic arthritis (JIA) 18 years after disease onset in a population‐based setting from the early biologic era.
M. Glerup, Veronika Rypdal, E. Arnstad, M. Ekelund, S. Peltoniemi, K. Aalto, M. Rygg, P. Toftedal, S. Nielsen, A. Fasth, L. Berntson, E. Nordal, T. Herlin   +12 more
semanticscholar   +1 more source